Loading
IARC estimates 69,739 new cancer cases and 44,261 cancer deaths in Democratic Republic of the Congo in 2024; the commonest new cancers are cervix uteri, breast and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Democratic Republic of the Congo's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 11,215 | 36.2 | Cervical cancer |
| Breast | 9,722 | 29.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 7,779 | 34.6 | Prostate cancer |
| Colorectum | 3,941 | 7.0 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 3,606 | 6.2 | Hepatocellular carcinoma |
| Oesophagus | 3,343 | 6.2 | Oesophageal cancer |
| Non-Hodgkin lymphoma | 2,522 | 3.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 2,387 | 3.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Kaposi sarcoma | 2,333 | 3.2 | Kaposi sarcoma |
| Stomach | 1,914 | 3.5 | Gastric & gastro-oesophageal junction cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 6,755 | 22.2 | Cervical cancer |
| Prostate | 4,766 | 21.4 | Prostate cancer |
| Breast | 4,606 | 14.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 3,251 | 5.7 | Hepatocellular carcinoma |
| Oesophagus | 3,048 | 5.7 | Oesophageal cancer |
| Colorectum | 2,256 | 4.1 | Colorectal cancer |
| Leukaemia | 1,687 | 2.4 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Stomach | 1,558 | 2.9 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 1,347 | 2.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Trachea, bronchus and lung | 1,187 | 2.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
No trial record in OnCo lists a site in Democratic Republic of the Congo. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Democratic Republic of the Congo.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Democratic Republic of the Congo is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Democratic Republic of the Congo is ranked 32 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.